sPLA2 inhibitor 2

• UNSPSC Description:

  sPLA2 inhibitor 2 (compound 6a) is a sPLA2 inhibitor, with IC50 of 0.0475 μM. sPLA2 inhibitor 2 can be used in diabetes research[1].

• Target Antigen:

  Phospholipase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/spla2-inhibitor-2.html

• Smiles:

  O=S(C1=CC=CC=C1)(NNC2=NC3=CC=CC=C3N=C2NNS(C4=CC=CC=C4)(=O)=O)=O

• Molecular Weight:

  470.52

• References & Citations:

  [1]Alasmary FAS, et al. Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes. J Enzyme Inhib Med Chem. 2024 Dec;39(1):2395985.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported